Provided is a pharmaceutical composition which contains pemafibrate, a salt thereof or a solvate thereof and one or more selected from the group consisting of a metal oxide, a dihydric alcohol, an ester species and a silicic acid compound and which has excellent storage stability. The pharmaceutical composition includes the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof； and (B) one or more selected from the group consisting of the following components (B-1) to (B-4): (B-1) a metal oxide； (B-2) a dihydric alcohol； (B-3) an ester species； and (B-4) a silicic acid compound, with component (A) and component (B) being substantially in non-contact with each other.
